You're reading the free version. Trader adds the live tape and alerts.
Start tracking
BRVE Buy Disclosure
Rickey James Paul · SEC Form 4 · Filed Aug 7, 2026
Buy
Calculated transaction value
$499.99K
Rickey James Paul Chief Financial Officer
BRVE
Braveheart Bio, Inc.
BRVE
Transaction date
Aug 7, 2026
Public filing date
Aug 7, 2026
Filing lag
Filed same day
BRVE daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 27,777 shares @ $18
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001470831-26-000804
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$499.99K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Braveheart Bio, Inc. BRVE Current | Buy | Aug 7, 2026 | $499.99K |
| Braveheart Bio, Inc. BRVE | Award | Aug 5, 2026 | $0 |